Bank of New York Mellon Corp Sells 33,112 Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)
Bank of New York Mellon Corp decreased its stake in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 4.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 738,973 shares of the biopharmaceutical company’s stock after selling 33,112 shares during […]
Bank of New York Mellon Corp decreased its stake in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 4.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 738,973 shares of the biopharmaceutical company’s stock after selling 33,112 shares during […]
